Quantcast
Last updated on April 18, 2014 at 15:51 EDT

Latest hepatitis B Stories

2014-03-06 08:31:51

MOSCOW, March 6, 2014 /PRNewswire/ -- A group of 48 patients infected with the hepatitis B virus (HBV) have been enrolled in the phase IIa clinical trial of Myrcludex B by Russian biotech company Hepatera Ltd. [http://www.hepatera.ru/?ln=en ] Hepatera is financed by Maxwell Biotech Venture Fund [http://www.maxwellbiotech.com ], set up with the participation of RVC [http://www.rusventure.ru/en ] - Russia's government fund of venture capital funds. Hepatera was...

2014-03-06 08:31:11

XIANYANG, China, March 6, 2014 /PRNewswire/-- Biostar Pharmaceuticals, Inc. (NASDAQ: BSPM) ("Biostar" or "corporation"), a China-based manufacturer and marketer of pharmaceutical and health supplement products for a variety of diseases and conditions, announced that it has signed a letter of intent with the Research Institute of Pharmaceuticals at Shaanxi University of Chinese Medicine to develop a new liver cancer drug based on Oleanolic Acid injection. In recent years, the new...

China Health Ministry Launches Investigation Into Baby Vaccine Deaths
2013-12-23 08:56:44

Gerard LeBlond for redorbit.com - Your Universe Online Six babies died in China after being inoculated with a hepatitis B vaccination. Four were from Guangdong, the other two were from Hunan and Sichuan. The hospitals that used the vaccine were ordered to remove the product from their shelves while the Health Ministry investigates the deaths as well as BioKangtai’s products. BioKangtai is a Shenzhen-based company that manufactured the vaccine. In a statement to the media the...

2013-12-05 12:29:02

ALPHARETTA, Ga., Dec. 5, 2013 /PRNewswire/ -- ViveBio, LLC announced today that ViveST(TM), its transformational specimen storage and transportation device, will be featured in a presentation at the 2013 HEP DART conference being held December 8-12, 2013 in Hawaii. The focus of HEP DART is to gather scientists and researchers to advance knowledge of ongoing drug development processes for Hepatitis B (HBV) and Hepatitis C (HCV). The presentation entitled, ViveST(TM) for HBV Testing:...

2013-11-11 00:21:13

TAINAN, Nov. 11, 2013 /PRNewswire/ -- Genovate Biotechnology Co. Ltd. (4130:TT) and ScinoPharm Taiwan Ltd. (1789:TT) announced today that they have jointly developed the highly potent oral generic drug Livepro (Entecavir), representing a new generation of drugs for the treatment of Hepatitis B. It is expected to be commercially available by the end of the year in Taiwan, accounting for more than NT$2 billion (US$70 million) worth of market opportunity. The new-generation oral...

2013-11-02 08:21:41

Presented November 3, 2013, Walter E. Washington Convention Center, Washington, DC WASHINGTON, Nov. 2, 2013 /PRNewswire/ -- Researchers from Australia presented their research on the underlying causes of liver cancer and cirrhosis deaths at the Annual Meeting of the American Association for the Study of Liver Diseases, concluding that these two diseases result in 1.75 million deaths each year. Viral hepatitis caused two thirds of those deaths. "If you consider deaths from hepatitis B...

2013-10-30 16:25:23

Company Expands U.S. Network to Meet Increasing Global Plasma Demand BOCA RATON, Fla., Oct. 30, 2013 /PRNewswire/ -- Biotest Pharmaceuticals Corporation (BPC), a leading developer of immunology biotherapeutic products, has opened its 14(th) U.S. plasma collection center. The state-of-the-art, 16,000 square foot facility is located at 3110 lake Washington Road in Melbourne, Florida and officially opened its doors on October 24, 2013. "We are pleased with the continued growth of our...

2013-10-08 23:26:24

At a ceremony held at the Pennsylvania Biotechnology Center on Oct. 7, the Hepatitis B Foundation’s research institute was officially renamed the Baruch S. Blumberg Institute. Doylestown, Pa. (PRWEB) October 08, 2013 At a ceremony held at the Pennsylvania Biotechnology Center on Oct. 7, the Hepatitis B Foundation’s research institute officially was renamed the Baruch S. Blumberg Institute. The new name honors the scientific legacy of the Foundation’s co-founder, the late Dr. Baruch...

2013-09-30 16:25:38

ALEXANDRIA, Va., Sept. 30, 2013 /PRNewswire/ -- Food and Drug Administration (FDA) announced the requirement of a Boxed Warning for the anti-cancer immunosuppressive drugs Arzerra (ofatumumab) and Rituxan (rituximab). The Boxed Warning is specific to the risk of reactivating hepatitis B virus (HBV) in patients who were previously infected with the virus. Use of these drugs in patients with prior HBV infection can result in severe liver damage if the virus is reactivated. The American...

2013-09-23 11:29:58

This discovery gives hope for a more effective and cheaper treatment strategy to millions worldwide suffering from chronic infections A recent discovery by scientists at A*STAR’s Singapore Institute for Clinical Sciences (SICS), in close collaboration with researchers at the Singapore Immunology Network (SIgN), provides hope for a new personalized treatment strategy that could use a patient’s own blood to treat the infection. This could help treat millions of people living with chronic...


Latest hepatitis B Reference Libraries

Hepatitis B
2013-02-25 09:11:23

Image Caption: This electron micrograph reveals the presence of hepatitis-B virus HBV "Dane particles", or virions. Credit: CDC/Wikipedia Hepatitis B: What Is It? Hepatitis simply means a swelling or inflammation of the liver. The type hepatitis that a person contracts (there are 5 common forms) affects their long-term prognosis. The most common and most severe of these different types of liver infection is Hepatitis B, which is caused by the hepatitis B virus (HBV). It is typically...

69_3e2a06a821d939ffdc2eab851bee21e9
2011-01-24 12:50:52

Hepatitis A, caused by hepatitis A virus, is an acute infectious disease of the liver that is transmitted person to person by ingestion of contaminated food or water or through direct contact with an infectious person. Millions of people are believed to become infected with HAV every year. The incubation period is two to six weeks and on average is 28 days. In less developed countries the HAV is usually contracted in early childhood. Clean water helps to decrease contraction of HAV. In 90%...

45_36624a455e3cd9a4152b7670308f0ffa
2011-01-20 19:14:56

Hepatitis B virus, HBV, is a part of the Hepadnaviridae family of viruses. HBV can lead to cirrhosis and hepatocellular carcinoma and has been linked to pancreatic cancer. It is classified as a species of the Orthohepadnavirus. Similar viruses have been found worldwide in great apes and monkeys. There a few different genotypes and they all differ by at least 8% of the sequence and have distinct geographical distributions and this has been associated with anthropological history. Type A is...

0_9255b919f71eff1fd4202c1dbb1795d2
2011-01-12 15:49:29

Hepadnaviruses can cause liver infections in humans and animals. The two recognized genera are Genus Orthohepadnavirus and Genus Avihepadnavirus. It has a small genome of partially double-stranded, partially single stranded circular DNA. It is a group 7 virus that uses an RNA intermediate during replication. Most people who come into contact with the virus are able to clear the infection alone although some cannot and usually progress to fulminant hepatitis. It can cause sever liver...

More Articles (4 articles) »